Business
Why the Polynovo (ASX:PNV) share price up 6% higher today // Motley Fool Australia
The Polynovo Ltd (ASX: PNV) share price is soaring higher today. This comes after the company announced an approval of a pivotal trial investigation device exemption (IDE).
During mid-morning trade, shares in the medical device company reached an intra-day high of $2.98. However, the Polynovo share price has since slightly retreated to $2.97, up 6.07% at the time of writing.
Let’s take a look at what Polynovo updated the market with.
FDA approval for clinical trial
Polynovo advised that the United States Food and Drug Administration (FDA) has approved the pivotal trial IDE for NovoSorb BTM. The authorisation allows Polynovo to begin patient recruitment, once various hospital Independent Review Boards grant approval.
Polynovo will…
-
General22 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General18 hours agoRegional house price growth outstrips capital cities
-
General18 hours agoRestaurants on the brink as business failures plateau
-
General15 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore